TLPH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TLPH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.
Talphera's current deferred tax liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.The historical data trend for Talphera's Current Deferred Taxes Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Talphera Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Current Deferred Taxes Liabilities | Get a 7-Day Free Trial | - | - | - | - | - |
Talphera Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Current Deferred Taxes Liabilities | Get a 7-Day Free Trial | - | - | - | - | - |
Thank you for viewing the detailed overview of Talphera's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.
Vincent J. Angotti | director, officer: Chief Executive Officer | C/O ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Pamela P Palmer | director, officer: Chief Medical Officer | C/O ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Jill Marie Broadfoot | director | 3545 JOHN HOPKINS COURT, SUITE 250, SAN DIEGO CA 92121 |
Marina Bozilenko | director | C/O ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Adrian Adams | director | C/O AUXILIUM PHARMACEUTICALS, INC., 640 LEE ROAD, CHESTERBROOK PA 19355 |
Mark G Edwards | director | ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020 |
Raffi Asadorian | officer: Chief Financial Officer | C/O ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Lawrence G Hamel | officer: Chief Development Officer | C/O ACELRX PHARMACEUTICALS INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Badri N Dasu | officer: Chief Engineering Officer | C/O ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Mark A Wan | director, 10 percent owner | C/O THREE ARCH PARTNERS, 3200 ALPINE RD, PORTOLA VALLEY CA 94028 |
Three Arch Associates Iii Lp | 10 percent owner | C/O THREE ARCH PARTNERS, 3200 ALPINE ROAD, PORTOLA VALLEY CA 94028 |
Wilfred E Jaeger | 10 percent owner | C/O THREE ARCH PARTNERS, 3200 ALPINE RD, PORTOLA VALLEY CA 94028 |
Three Arch Partners Iii Lp | 10 percent owner | |
Three Arch Partners Iv Lp | 10 percent owner | |
Three Arch Associates Iv Lp | 10 percent owner | 3200 ALPINE ROAD, PORTOLA VALLEY CA 94028 |
From GuruFocus
By PRNewswire PRNewswire • 11-14-2022
By PRNewswire • 01-09-2024
By PRNewswire PRNewswire • 03-01-2023
By PRNewswire PRNewswire • 12-08-2022
By PRNewswire PRNewswire • 08-25-2022
By PRNewswire • 01-18-2024
By PRNewswire • 08-10-2023
By PRNewswire PRNewswire • 05-10-2023
By PRNewswire PRNewswire • 10-31-2022
By GuruFocus Research • 09-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.